High-Stakes Moves: Nvidias China Focus, Teslas Safety Recall, and Apple’s Expansion Challenges
Tuesday, Nov 26, 2024 5:31 pm ET
2min read 1. Nvidia (Nasdaq: NVDA)
Nvidia gained mildly by 0.66%, with the trading volume of 25.84B. NVIDIA executives visited China, highlighting the company's focus on this key market. Discussions with the Chinese Ministry of Commerce underscored NVIDIA's commitment to its business in China, signaling the company's strategic importance despite broader tensions.
2. Tesla (Nasdaq: TSLA)
Tesla dipped mildly by -0.11%, with the trading volume of 20.95B. Tesla is recalling 27 vehicles in the US due to seatback frame issues, risking passenger safety. The company also released a video highlighting the safety of its FSD system, while maintaining a top spot in the EV customer satisfaction rankings alongside GAC Aion and BYD.
3. Microstrategy Incorporated (Nasdaq: MSTR)
Microstrategy Incorporated plunged by -12.33%, with the trading volume of 17.50B. MicroStrategy acquired approximately 55,500 bitcoins for around $5.4 billion between November 18 and 24, 2024. The company disclosed five insider trades on November 25, involving Director Graham Stephen X's purchase of 20,000 shares on November 21, 2024.
4. Apple (Nasdaq: AAPL)
Apple gained mildly by 0.94%, with the trading volume of 10.76B. Apple's self-developed 5G faces signal issues compared to Qualcomm; Tap to Pay on iPhone launched in New Zealand; Brazilian regulators demand removal of in-app purchase restrictions, following a complaint by MercadoLibre. Apple remains at risk of facing fines in Brazil.
5. Microsoft (Nasdaq: MSFT)
Microsoft gained mildly by 2.20%, with the trading volume of 9.82B. Microsoft launched the Semantic Kernel's OpenAPI extension for AI model integration, supporting .NET and Python. Simultaneously, Microsoft 365 services faced a major outage, affecting applications like Outlook and Teams. Barclays noted that Google's antitrust case minimally impacts Microsoft.
6. Amazon (Nasdaq: AMZN)
Amazon.Com gained solidly by 3.18%, with the trading volume of 8.56B. Amazon's third-quarter 2024 revenue reached $450.17 billion, with net income rising 11.2%. Redburn Atlantic maintains a buy rating with a $235 target price. Amazon is under antitrust investigation in Japan for pressuring sellers to reduce prices on its platform.
7. Meta Platforms (Nasdaq: META)
Meta Platforms gained mildly by 1.49%, with the trading volume of 5.92B. Meta Platforms and OpenAI will train AI models using African languages to address dialect shortages. The FTC's antitrust case against Meta will begin in April 2025. The US Supreme Court has allowed a class-action lawsuit against Meta over the Cambridge Analytica privacy scandal.
8. Eli Lilly Andmpany (NYSE: LLY)
Eli Lilly Andmpany gained solidly by 4.54%, with the trading volume of 5.23B. Eli Lilly saw a surge in its stock due to a U.S. proposal to expand Medicare and Medicaid coverage for weight-loss drugs, potentially reducing costs for millions of Americans. Its new drug Tirzepatide has filed a new application for indication in China.
9. Amgen (Nasdaq: AMGN)
Amgen dropped solidly by -4.76%, with the trading volume of 4.56B. Amgen reported that its experimental obesity drug MariTide helps patients lose up to 20% of body weight after one year, but Wall Street expressed dissatisfaction with the data.
10. Advanced Micro Devices (Nasdaq: AMD)
Advanced Micro Devices dipped mildly by -2.42%, with the trading volume of 4.41B. Advanced Micro Devices plans to re-enter the smartphone chip market using TSMC's 3nm process, which could strengthen its position in the mobile sector and support TSMC's production capacity. Additionally, TSMC's new 2nm facility in Kaohsiung could attract AMD as an initial client.
Nvidia gained mildly by 0.66%, with the trading volume of 25.84B. NVIDIA executives visited China, highlighting the company's focus on this key market. Discussions with the Chinese Ministry of Commerce underscored NVIDIA's commitment to its business in China, signaling the company's strategic importance despite broader tensions.
2. Tesla (Nasdaq: TSLA)
Tesla dipped mildly by -0.11%, with the trading volume of 20.95B. Tesla is recalling 27 vehicles in the US due to seatback frame issues, risking passenger safety. The company also released a video highlighting the safety of its FSD system, while maintaining a top spot in the EV customer satisfaction rankings alongside GAC Aion and BYD.
3. Microstrategy Incorporated (Nasdaq: MSTR)
Microstrategy Incorporated plunged by -12.33%, with the trading volume of 17.50B. MicroStrategy acquired approximately 55,500 bitcoins for around $5.4 billion between November 18 and 24, 2024. The company disclosed five insider trades on November 25, involving Director Graham Stephen X's purchase of 20,000 shares on November 21, 2024.
4. Apple (Nasdaq: AAPL)
Apple gained mildly by 0.94%, with the trading volume of 10.76B. Apple's self-developed 5G faces signal issues compared to Qualcomm; Tap to Pay on iPhone launched in New Zealand; Brazilian regulators demand removal of in-app purchase restrictions, following a complaint by MercadoLibre. Apple remains at risk of facing fines in Brazil.
5. Microsoft (Nasdaq: MSFT)
Microsoft gained mildly by 2.20%, with the trading volume of 9.82B. Microsoft launched the Semantic Kernel's OpenAPI extension for AI model integration, supporting .NET and Python. Simultaneously, Microsoft 365 services faced a major outage, affecting applications like Outlook and Teams. Barclays noted that Google's antitrust case minimally impacts Microsoft.
6. Amazon (Nasdaq: AMZN)
Amazon.Com gained solidly by 3.18%, with the trading volume of 8.56B. Amazon's third-quarter 2024 revenue reached $450.17 billion, with net income rising 11.2%. Redburn Atlantic maintains a buy rating with a $235 target price. Amazon is under antitrust investigation in Japan for pressuring sellers to reduce prices on its platform.
7. Meta Platforms (Nasdaq: META)
Meta Platforms gained mildly by 1.49%, with the trading volume of 5.92B. Meta Platforms and OpenAI will train AI models using African languages to address dialect shortages. The FTC's antitrust case against Meta will begin in April 2025. The US Supreme Court has allowed a class-action lawsuit against Meta over the Cambridge Analytica privacy scandal.
8. Eli Lilly Andmpany (NYSE: LLY)
Eli Lilly Andmpany gained solidly by 4.54%, with the trading volume of 5.23B. Eli Lilly saw a surge in its stock due to a U.S. proposal to expand Medicare and Medicaid coverage for weight-loss drugs, potentially reducing costs for millions of Americans. Its new drug Tirzepatide has filed a new application for indication in China.
9. Amgen (Nasdaq: AMGN)
Amgen dropped solidly by -4.76%, with the trading volume of 4.56B. Amgen reported that its experimental obesity drug MariTide helps patients lose up to 20% of body weight after one year, but Wall Street expressed dissatisfaction with the data.
10. Advanced Micro Devices (Nasdaq: AMD)
Advanced Micro Devices dipped mildly by -2.42%, with the trading volume of 4.41B. Advanced Micro Devices plans to re-enter the smartphone chip market using TSMC's 3nm process, which could strengthen its position in the mobile sector and support TSMC's production capacity. Additionally, TSMC's new 2nm facility in Kaohsiung could attract AMD as an initial client.
Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.